Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
PainChek Ltd ( (AU:PCK) ) has shared an update.
PainChek Ltd has announced the expiry and cessation of 15,686,749 listed options (ASX code PCKAY) that carried an exercise price of A$0.50 and were due to expire on 19 December 2025, with the options lapsing unexercised. The expiry slightly simplifies the company’s capital structure by removing a large block of out-of-the-money options from its issued securities, which may clarify the potential future dilution profile for existing shareholders but does not immediately affect PainChek’s current cash position or operations.
More about PainChek Ltd
PainChek Ltd is an ASX-listed company (code: PCK) operating in the healthcare technology sector, best known for its digital pain assessment tools that use smart devices and AI-driven analytics to help clinicians and carers assess and manage pain, particularly in aged care and other clinical settings.
Average Trading Volume: 470,756
Technical Sentiment Signal: Sell
Current Market Cap: A$61.66M
Learn more about PCK stock on TipRanks’ Stock Analysis page.